New treatment for enlarged prostate symptoms
Part of Kidney & urinary clinical trials.
This trial tests a new procedure called irreversible electroporation (IRE) that uses electrical pulses to treat an enlarged prostate. It aims to improve urinary symptoms in men with benign prostatic hyperplasia (BPH) and might offer an alternative to surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 50 or older.
- You have moderate to severe urinary symptoms from an enlarged prostate.
- Your prostate size is between 30 and 80 cubic centimeters.
- You have not had prior surgery or procedures for an enlarged prostate.
- You do not have a pacemaker or other implanted electrical device.
- You are willing to follow study procedures and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, non-surgical treatment called irreversible electroporation (IRE) for men with early-stage prostate cancer that hasn't spread. It uses short electrical pulses to destroy cancer cells while sparing healthy tissue nearby.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This trial tests a new focal treatment called IRE (irreversible electroporation) that uses electrical pulses to destroy prostate cancer cells while sparing healthy tissue. It is for men with intermediate-risk prostate cancer that has not spread outside the prostate gland.
This study compares a new treatment that uses high-frequency electric pulses to shrink the prostate, versus standard care for enlarged prostate (BPH). It aims to relieve symptoms like frequent or difficult urination with a minimally invasive option.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
This trial compares two catheter-based treatments—TUMT and PAE—to see which better reduces severe urinary symptoms caused by an enlarged prostate (BPH). It may help you choose a treatment option if medicines are not suitable or you still have significant symptoms.
Hear when a new Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.